Immediate Impact
10 from Science/Nature 53 standout
Citing Papers
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Stimuli-responsive ferroptosis for cancer therapy
2023 Standout
Works of Ellen Bolotin being referenced
A randomized, placebo‐controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild‐type KRAS who have received first‐line systemic therapy
2016
Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ellen Bolotin | 142 | 177 | 68 | 354 | 17 | 573 | |
| Franz Martin Fink | 94 | 124 | 22 | 218 | 18 | 598 | |
| G. Kaplanski | 93 | 62 | 49 | 192 | 20 | 507 | |
| Richard M. Crapper | 95 | 78 | 14 | 254 | 19 | 623 | |
| Shlomit Orgad | 47 | 148 | 38 | 303 | 26 | 614 | |
| J. W. Gratama | 82 | 270 | 19 | 329 | 26 | 621 | |
| N Carpentier | 47 | 99 | 24 | 251 | 17 | 479 | |
| Naoko Akiyama | 213 | 51 | 36 | 453 | 14 | 630 | |
| Gordon K. Lam | 55 | 39 | 64 | 194 | 12 | 568 | |
| Lydia M. Evans | 198 | 53 | 27 | 260 | 16 | 635 | |
| Annie Soulié | 69 | 120 | 9 | 280 | 19 | 512 |
All Works
Loading papers...